BCR-ABL1 transcript decline ratio combined BCR-ABL1(IS) as a precise predictor for imatinib response and outcome in the patients with chronic myeloid leukemia

Purpose: The early BCR-ABL1 reduction had the prognostic impact of the chronic-phase chronic myeloid leukemia (CML-CP) patients. This study was to find a more precise early prognosis index at 3 months in the patients with newly diagnosed CML-CP, especially for the patients with BCR-ABL1(IS) >10%....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Cai, Zhimei, Jia, Xiting, Zi, Jie, Song, Huihui, Wang, Shujun, McGrath, Mary, Zhao, Lidong, Song, Chunhua, Ge, Zheng
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052929/
https://ncbi.nlm.nih.gov/pubmed/32127950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.38752
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados